Claudine Prowse

Claudine Prowse

Keine laufenden Positionen mehr
Health Technology
Finance
Consumer Services

Profil

Claudine Prowse is currently a Partner at JP Morgan Life Sciences Private Capital since 2023.
Former positions include Executive Director-Corporate Development at Ionis Pharmaceuticals, Inc., Research Analyst at CIBC World Markets Corp.
(Old), Vice President-Investor Relations at Human Genome Sciences, Inc., Vice President-Investor Relations & Planning at Biogen, Inc., Vice President-Strategy & Investor Relations at Inotek Pharmaceuticals Corp., Research Analyst at Oppenheimer & Co., Inc. (Broker) in 2008, Senior VP-Communications & Investor Relations at Kite Pharma, Inc., Vice President & Product Manager at Leerink Swann & Co., Vice President & Product Manager at MEDACorp, Inc., and Senior VP-Strategy & Corporate Development at Rocket Pharmaceuticals, Inc. from 2018 to 2021.
Education includes graduate studies completed in 2001 at UC San Diego School of Medicine and undergraduate studies completed in 1994 at the University of California San Diego.

Aktive Positionen von Claudine Prowse

UnternehmenPositionBeginn

Ehemalige bekannte Positionen von Claudine Prowse

UnternehmenPositionEnde
ROCKET PHARMACEUTICALS, INC. Investor Relations Kontakt 01.08.2021
Analyst-Equity 31.01.2008
Analyst-Equity 13.01.2008
Corporate Officer/Principal -
Corporate Officer/Principal -
Sehen Sie sich die Erfahrung von Claudine Prowse im Detail an

Ausbildung von Claudine Prowse

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

89

Beziehungen ersten Grades

12

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen12

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Health Technology

Consumer Services

Finance

Commercial Services

Health Technology

  1. Börse
  2. Insiders
  3. Claudine Prowse